Showing results (81-90 of 144) with videos related to
Sort By:
Pageof 15
Hepatology (Baltimore, Md.)|March 14, 2018
Long-term outcomes and predictive scores for hepatocellular carcinoma and hepatitis B surface antigen seroclearance after hepatitis B e-antigen seroclearanceJames Fung, Ka-Shing Cheung, Danny Ka-Ho Wong, et al.Journal of Gastroenterology|October 9, 2015
Hepatitis B surface antigen seroclearance during nucleoside analogue therapy: surface antigen kinetics, outcomes, and durabilityWai-Kay Seto, Ka-Shing Cheung, Danny Ka-Ho Wong, et al.Journal of Clinical Gastroenterology|October 30, 2020
Phenotypic Changes of PD-1 and GITR in T Cells Are Associated With Hepatitis B Surface Antigen SeroclearanceFen Liu, Saisai Zhang, Danny Ka-Ho Wong, et al.Journal of Gastroenterology and Hepatology|April 3, 2022
Magnetic resonance imaging metrics and the predictability of adverse outcomes in on-treatment Asian chronic hepatitis BRex Wan-Hin Hui, Keith Wan-Hang Chiu, Lung Yi Mak, et al.Liver International : Official Journal of the International Association for the Study of the Liver|October 17, 2015
Longitudinal profiles of highly sensitive hepatitis B surface antigen levels: re-evaluation of HBsAg seroclearanceWai-Kay Seto, Yasuhito Tanaka, Danny K-H Wong, et al.Cancer Medicine|April 30, 2022
Association between antibiotic consumption and colon and rectal cancer development in older individuals: A territory-wide studyKa Shing Cheung, Esther W Chan, Anthony Tam, et al.Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|January 9, 2023
A longitudinal study to detect hepatitis B surface and core-related antigens in chronic hepatitis B patients with hepatitis B surface antigen seroclearance using highly sensitive assaysDanny Ka-Ho Wong, Takako Inoue, Lung-Yi Mak, et al.Hepatology International|June 21, 2021
Reduced hepatic steatosis is associated with higher risk of hepatocellular carcinoma in chronic hepatitis B infectionLung-Yi Mak, Rex Wan-Hin Hui, James Fung, et al.Pharmacoepidemiology and Drug Safety|September 18, 2025
Risk of Ischaemic Stroke Varies With Antithrombotic Drugs Use in Proton Pump Inhibitor Users: A Self-Controlled Case Series StudyMin Fan, Joseph E Blais, Ian C K Wong, et al.Clinical and Molecular Hepatology|May 11, 2022
Effect of moderate-to-severe hepatic steatosis on neutralising antibody response among BNT162b2 and CoronaVac recipientsKa Shing Cheung, Lok Ka Lam, Rex Wan Hin Hui, et al.Pageof 15